Tumor necrosis factor α is a risk factor for infection in peritoneal dialysis patients
Eunjung Kang, Seihran Kim, Hwa Jung Lee, Inhwee Park, Heungsoo Kim, Gyu-Tae Shin
Korean J Intern Med. 2016;31(4):722-729. Published online 2016 Mar 22 DOI: https://doi.org/10.3904/kjim.2015.230
Citations to this article as recorded by 
Multiplex proteomics as risk predictor of infection in patients treated with hemodialysis—A prospective multicenter study
Rie Glerup, My Svensson, Lasse H. Jakobsen, Bengt Fellstrøm, Jens D. Jensen, Jeppe H. Christensen
Hemodialysis International.2022; 26(2): 191. CrossRef
Assessment of hemodialysis clinical practices using polyaryl ether sulfone-polyvinylpyrrolidone (PAES: PVP) clinical membrane: Modeling of in vitro fibrinogen adsorption, in situ synchrotron-based imaging, and clinical inflammatory biomarkers investigatio
Heloisa Westphalen, Amira Abdelrasoul, Ahmed Shoker, Ning Zhu
Separation and Purification Technology.2021; 259: 118136. CrossRef
Activation of chronic inflammation and comorbidity in end-stage renal disease patients treated with continuous ambulatory peritoneal dialysis.
I. M. Shifris, I. O. Dudar, V. E. Driyanska, А. U. Shymova
Medicni perspektivi (Medical perspectives).2020; 25(2): 108. CrossRef
The Behavior of the Type of Peritoneal Transport in the Inflammatory and Oxidative Status in Adults Under Peritoneal Dialysis
Julio Alejandro Gutiérrez-Prieto, Javier Soto-Vargas, Renato Parra-Michel, Héctor Leonardo Pazarín-Villaseñor, Andrés García-Sánchez, Alejandra Guillermina Miranda-Díaz
Frontiers in Medicine.2019;[Epub] CrossRef